Abstrakt

Przypisy

• 1. Alejandria M.M., Lansang M.A., Dans L.F., Mantaring J.B.3rd: Intravenousimmunoglobulin for treating sepsis, severe sepsis and septicshock. Cochrane Database Syst. Rev., 2013; 9: CD001090
  Google Scholar
• 2. Armstrong-James D., Teo I.A., Shrivastava S., Petrou M.A., TaubeD., Dorling A., Shaunak S.: Exogenous interferon-g immunotherapyfor invasive fungal infections in kidney transplant patients. Am. J.Transplant., 2010; 10: 1796-1803
  Google Scholar
• 3. Borthwick E.M., Hill C.J., Rabindranath K.S., Maxwell A.P., McAuleyD.F., Blackwood B.: High-volume haemofiltration for sepsis. CochraneDatabase Syst. Rev., 2013; 1: CD008075
  Google Scholar
• 4. Brahmer J.R., Tykodi S.S., Chow L.Q., Hwu W.J., Topalian S.L., HwuP., Drake C.G., Camacho L.H., Kauh J., Odunsi K., Pitot H.C., HamidO., Bhatia S., Martins R., Eaton K. i wsp.: Safety and activity of anti–PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med.,2012; 366: 2455-2465
  Google Scholar
• 5. Busund R., Koukline V., Utrobin U., Nedashkovsky E.: Plasmapheresisin severe sepsis and septic shock: a prospective, randomised,controlled trial. Intensive Care Med., 2002; 28: 1434-1439
  Google Scholar
• 6. Chang K.C., Burnham C.A., Compton S.M., Rasche D.P., MazuskiR.J., McDonough J.S., Unsinger J., Korman A.J., Green J.M., HotchkissR.S.: Blockade of the negative co-stimulatory molecules PD-1 andCTLA-4 improves survival in primary and secondary fungal sepsis.Crit. Care, 2013; 17: R85
  Google Scholar
• 7. Clark E., Molnar A.O., Joannes-Boyau O., Honoré P.M., Sikora L.,Bagshaw S.M.: High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit. Care, 2014; 18: R7
  Google Scholar
• 8. Cruz D.N., Antonelli M., Fumagalli R., Foltran F., Brienza N., DonatiA., Malcangi V., Petrini F., Volta G., Bobbio Pallavicini F.M., RottoliF., Giunta F., Ronco C.: Early use of polymyxin B hemoperfusion inabdominal septic shock: the EUPHAS randomized controlled trial.JAMA, 2009; 301: 2445-2452
  Google Scholar
• 9. Daviaud F., Grimaldi D., Dechartres A., Charpentier J., Geri G.,Marin N., Chiche J.D., Cariou A., Mira J.P., Pène F.:Timing and causesof death in septic shock. Ann. Intensive Care, 2015; 5: 16
  Google Scholar
• 10. Dellinger R.P., Carlet J.M., Masur H., Gerlach H., Calandra T., CohenJ., Gea-Banacloche J., Keh D., Marshall J.C., Parker M.M., RamsayG., Zimmerman J.L., Vincent J.L., Levy M.M., Surviving Sepsis CampaignManagement Guidelines Committee: Surviving Sepsis Campaignguidelines for management of severe sepsis and septic shock. Crit.Care Med., 2004; 32: 858-873
  Google Scholar
• 11. Delsing C.E., Gresnigt M.S., Leentjens J., Preijers F., Frager F.A.,Kox M., Monneret G., Venet F., Bleeker-Rovers C.P., van de VeerdonkF.L., Pickkers P., Pachot A., Kullberg B.J., Netea M.G.: Interferon-g asadjunctive immunotherapy for invasive fungal infections: a caseseries. BMC Infect. Dis., 2014; 14: 166
  Google Scholar
• 12. Döcke W.D., Höflich C., Davis K.A., Röttgers K., Meisel C., KieferP., Weber S.U., Hedwig-Geissing M., Kreuzfelder E., Tschentscher P.,Nebe T., Engel A., Monneret G., Spittler A., Schmolke K. i wsp.: Monitoringtemporary immunodepression by flow cytometric measurementof monocytic HLA-DR expression: a multicenter standardizedstudy. Clin. Chem., 2005; 51: 2341-2347
  Google Scholar
• 13. Girardot T., Venet F., Rimmelé T.: Immunomodulation: the futurefor sepsis? W: Annual update in intensive care and emergencymedicine 2016, red.: Springer International Publishing, Switzerland2016, 49-59
  Google Scholar
• 14. Haase M., Bellomo R., Baldwin I., Haase-Fielitz A., Fealy N., DavenportP., Morgera S., Goehl H., Storr M., Boyce N., Neumayer H.H.:Hemodialysis membrane with a high-molecular-weight cutoff andcytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial. Am. J. Kidney Dis., 2007; 50: 296-304
  Google Scholar
• 15. Hjorth V., Stenlund G.: Plasmapheresis as part of the treatmentfor septic shock. Scand. J. Infect. Dis., 2000; 32: 511-514
  Google Scholar
• 16. Holzer K., Konietzny P., Wilhelm K., Encke A., Henrich D.: Phagocytosisby emigrated, intra-abdominal neutrophils is depressed duringhuman secondary peritonitis. Eur. Surg. Res., 2002; 34: 275-284
  Google Scholar
• 17. Honore P.M., Jacobs R., Joannes-Boyau O., De Regt J., De Waele E.,van Gorp V., Boer W., Verfaillie L., Spapen H.D.: Newly designed CRRTmembranes for sepsis and SIRS – a pragmatic approach for bedsideintensivists summarizing the more recent advances: a systematicstructured review. ASAIO J., 2013; 59: 99-106
  Google Scholar
• 18. Hotchkiss R.S., Karl I.E.: The pathophysiology and treatment ofsepsis. N. Engl. J. Med., 2003; 348: 138-150
  Google Scholar
• 19. Hotchkiss R.S., Monneret G., Payen D.: Sepsis-induced immunosuppression:from cellular dysfunctions to immunotherapy. Nat.Rev. Immunol., 2013; 13: 862-874
  Google Scholar
• 20. Joannes-Boyau O., Honore P.M., Boer W., Collin V.: Are the synergisticeffects of high-volume haemofiltration and enhanced adsorptionthe missing key in sepsis modulation? Nephrol. Dial. Transplant.,2009; 24: 354-357
  Google Scholar
• 21. Joannes-Boyau O., Honoré P.M., Perez P., Bagshaw S.M., GrandH., Canivet J.L., Dewitte A., Flamens C., Pujol W., Grandoulier A.S.,Fleureau C., Jacobs R., Broux C., Floch H., Branchard O. i wsp.: High–volume versus standard-volume haemofiltration for septic shockpatients with acute kidney injury (IVOIRE study): a multicentre randomizedcontrolled trial. Intensive Care Med., 2013; 39: 1535-1546
  Google Scholar
• 22. Kellum J.A., Johnson J.P., Kramer D., Palevsky P., Brady J.J., PinskyM.R.: Diffusive vs. convective therapy: effects on mediators of inflammationin patient with severe systemic inflammatory responsesyndrome. Crit. Care Med., 1998; 26: 1995-2000
  Google Scholar
• 23. Khan H.A.: Zymosan-induced luminol-dependent chemiluminescenceresponse of circulating and extravasated leukocytes inexperimental sepsis. Mediators Inflamm., 2004; 13: 123-125
  Google Scholar
• 24. Klein D.J., Foster D., Schorr C.A., Kazempour K., Walker P.M., DellingerR.P.: The EUPHRATES trial (Evaluating the Use of Polymyxin BHemoperfusion in a Randomized controlled trial of Adults Treatedfor Endotoxemia and Septic shock): study protocol for a randomizedcontrolled trial. Trials, 2014; 15: 218
  Google Scholar
• 25. Landelle C., Lepape A., Voirin N., Tognet E., Venet F., Bohé J., VanhemsP., Monneret G.: Low monocyte human leukocyte antigen-DRis independently associated with nosocomial infections after septicshock. Intensive Care Med., 2010; 36: 1859-1866
  Google Scholar
• 26. Leentjens J., Kox M., Koch R.M., Preijers F., Joosten L.A., van derHoeven J.G., Netea M.G., Pickkers P.: Reversal of immunoparalysis inhumans in vivo: a double-blind, placebo-controlled, randomized pilotstudy. Am. J. Respir. Crit. Care Med., 2012; 186: 838-845
  Google Scholar
• 27. Leentjens J., Kox M., van der Hoeven J.G., Netea M.G., Pickkers P.:Immunotherapy for the adjunctive treatment of sepsis: from immunosuppressionto immunostimulation. Time for a paradigm change?Am. J. Respir. Crit. Care Med., 2013; 187: 1287-1293
  Google Scholar
• 28. Lekkou A., Karakantza M., Mouzaki A., Kalfarentzos F., GogosC.A.: Cytokine production and monocyte HLA-DR expression as predictorsof outcome for patients with community-acquired severeinfections. Clin. Diagn. Lab. Immunol., 2004; 11: 161-167
  Google Scholar
• 29. Livigni S., Bertolini G., Rossi C., Ferrari F., Giardino M., Pozzato M., Remuzzi G.: Efficacy of coupled plasma filtration adsorption(CPFA) in patients with septic shock: a multicenter randomised controlledclinical trial. BMJ Open, 2014; 4: e003536
  Google Scholar
• 30. Łysenko L.: New methods of monitoring in sepsis – flow cytometry.Sepsis, 2012; 2: 53-61
  Google Scholar
• 31. Mañez R., Kusne S., Linden P., Gonzalez-Pinto I., Bonet H., KramerD., Fung J.J., Starzl T.E.: Temporary withdrawal of immunosuppressionfor life-threatening infections after liver transplantation.Transplantation, 1994; 57: 149-151
  Google Scholar
• 32. Mao H.J., Yu S., Yu X.B., Zhang B., Zhang L., Xu X.R., Wang X.Y.,Xing C.Y.: Effects of coupled plasma filtration adsorption on immunefunction of patients with multiple organ dysfunction syndrome.Int. J. Artif. Organs, 2009; 32: 31-38
  Google Scholar
• 33. Martí-Carvajal A.J., Solà I., Lathyris D., Cardona A.F.: Human recombinantactivated protein C for severe sepsis. Cochrane DatabaseSyst. Rev., 2012; 3: CD004388
  Google Scholar
• 34. Meisel C., Schefold J.C., Pschowski R., Baumann T., Hetzger K.,Gregor J., Weber-Carstens S., Hasper D., Keh D., Zuckermann H.,Reinke P., Volk H.D.: Granulocyte-macrophage colony-stimulatingfactor to reverse sepsis-associated immunosuppression: a double–blind, randomized, placebo-controlled multicenter trial. Am. J. Respir.Crit. Care Med., 2009; 180: 640-648
  Google Scholar
• 35. Monneret G., Finck M.E., Venet F., Debard A.L., Bohé J., BienvenuJ., Lepape A.: The anti-inflammatory response dominates afterseptic shock: association of low monocyte HLA-DR expression andhigh interleukin-10 concentration. Immunol. Lett., 2004; 95: 193-198
  Google Scholar
• 36. Monneret G., Venet F.: Sepsis-induced immune alterations monitoringby flow cytometry as a promising tool for individualizedtherapy. Cytometry B Clin. Cytom., 2016; 90: 376-386
  Google Scholar
• 37. Monneret G., Venet F., Pachot A., Lepape A.: Monitoring immunedysfunctions in septic patients: a new skin for the old ceremony.Mol. Med., 2008; 14: 64-78
  Google Scholar
• 38. Morgera S., Haase M., Kuss T., Vargas-Hein O., Zuckermann-BeckerH., Melzer C., Krieg H., Wegner B., Bellomo R., Neumayer H.H.:Pilot study on the effects of high cutoff hemofiltration on the needfor norepinephrine in septic patients with acute renal failure. Crit.Care Med., 2006; 34: 2099-2104
  Google Scholar
• 39. Payen D.M., Guilhot J., Launey Y., Lukaszewicz A.C., Kaaki M.,Veber B., Pottecher J., Joannes-Boyau O., Martin-Lefevre L., JabaudonM., Mimoz O., Coudroy R., Ferrandière M., Kipnis E., Vela C. i wsp.:Early use of polymyxin B hemoperfusion in patients with septicshock due to peritonitis: a multicenter randomized control trial.Intensive Care Med., 2015; 41: 975-984
  Google Scholar
• 40. Pène F., Picckers P., Hotchkiss R.S.: Is this critically ill patientimmunocompromised? Intensive Care Med., 2016; 42: 1051-1054
  Google Scholar
• 41. Peng Z.Y., Carter M.J., Kellum J.A.: Effects of hemoadsorption oncytokine removal and short-term survival in septic rats. Crit. CareMed., 2008; 36: 1573-1577
  Google Scholar
• 42. Petersen L., Andersen P.K., Sørensen T.I.: Genetic influences onincidence and case-fatality of infectious disease. PLoS One, 2010;5: e10603
  Google Scholar
• 43. Quenot J.P., Binquet C., Kara F., Martinet O., Ganster F., NavellouJ.C., Castelain V., Barraud D., Cousson J., Louis G., Perez P., KuteifanK., Noirot A., Badie J., Mezher C., Lessire H., Pavon A.: The epidemiologyof septic shock in French intensive care units: the prospectivemulticenter cohort EPISS study. Crit. Care, 2013; 17: R65
  Google Scholar
• 44. Quinn L.M., Drakeford C., O’Donnell J.S., Preston R.J.: Engineeringactivated protein C to maximize therapeutic efficacy. Biochem. Soc.Trans., 2015; 43: 691-695
  Google Scholar
• 45. Reeves J.H., Butt W.W., Shann F., Layton J.E., Stewart A., WaringP.M., Presneill J.J.: Continuous plasmafiltration in sepsis syndrome.Plasma filtration in Sepsis Study Group. Crit. Care Med., 1999; 27:2096-2104
  Google Scholar
• 46. Rhodes A., Evans L.E., Alhazzani W., Levy M.M., Antonelli M.,Ferrer R., Kumar A., Sevransky J.E., Sprung C.L., Nunnally M.E., RochwergB., Rubenfeld G.D., Angus D.C., Annane D., Beale R.J. i wsp.:Surviving Sepsis Campaign: International Guidelines for Managementof Sepsis and Septic Shock: 2016. Intensive Care Med., 2017;43: 304-377
  Google Scholar
• 47. Rimmelé T., Assadi A., Cattenoz M., Desebbe O., Lambert C., BoselliE., Goudable J., Etienne J., Chassard D., Bricca G., Allaouchiche B.:High-volume haemofiltration with a new haemofiltration membranehaving enhanced adsorption properties in septic pigs. Nephrol. Dial.Transplant., 2009; 24: 421-427
  Google Scholar
• 48. Rimmelé T., Hayi-Slayman D., Page M., Rada H., Monchi M., AllaouchicheB.: Cascade hemofiltration: principle, first experimentaldata. Ann. Fr. Anesth. Reanim., 2009; 28: 249-252
  Google Scholar
• 49. Rimmelé T., Kaynar A.M., McLaughlin J.N., Bishop J.V., FedorchakM.V., Chuasuwan A., Peng Z., Singbartl K., Frederick D.R., ZhuL., Carter M., Federspiel W.J., Zeevi A., Kellum J.A.: Leukocyte captureand modulation of cell-mediated immunity during human sepsis:an ex vivo study. Crit. Care, 2013; 17: R59
  Google Scholar
• 50. Rimmelé T., Kellum J.A.: High-volume hemofiltration in theintensive care unit: a blood purification therapy. Anesthesiology,2012; 116: 1377-1387
  Google Scholar
• 51. Ronco C., Brendolan A., Lonnemann G., Bellomo R., Piccinni P.,Digito A., Dan M., Irone M., La Greca G., Inguaggiato P., Maggiore U.,De Nitti C., Wratten M.L., Ricci Z., Tetta C.: A pilot study of coupledplasma filtration with adsorption in septic shock. Crit. Care Med.,2002; 30: 1250-1255
  Google Scholar
• 52. Saeed S., Quintin J., Kerstens H.H., Rao N.A., Aghajanirefah A.,Matarese F., Cheng S-C., Ratter J., Berentsen K., van der Ent M.A.,Sharifi N., Janssen-Megens E.M., Huurne M.T., Mandoli A., van SchaikT. i wsp.: Epigenetic programming during monocyte to macrophagedifferentiation and trained innate immunity. Science, 2014;345: 1251086
  Google Scholar
• 53. Sprung C.L., Annane D., Keh D., Moreno R., Singer M., FreivogelK., Weiss Y.G., Benbenishty J., Kalenka A., Forst H., Laterre P.F., ReinhartK., Cuthbertson B.H., Payen D., Briegel J.: Hydrocortisone therapyfor patients with septic shock. N. Engl. J. Med., 2008; 358: 111-124
  Google Scholar
• 54. Stephan F., Yang K., Tankovic J., Soussy C.J., Dhonneur G., DuvaldestinP., Brochard L., Brun-Buisson C., Harf A., Delclaux C.: Impairmentof polymorphonuclear neutrophil functions precedes nosocomialinfections in critically ill patients. Crit. Care Med., 2002;30: 315-322
  Google Scholar
• 55. Stojewska M., Wąsek-Buko M., Jakub B., Wiśniewska-Ulfig D., Goleniowska-Król A., Szymańska A., Godula-Stuglik U.: Evaluationof serum chemokine RANTES concentration as a biomarker in thediagnosis of early-onset severe infections in neonates. Postępy Hig.Med. Dośw., 2016; 70: 272-279
  Google Scholar
• 56. Unsinger J., McGlynn M., Kasten K.R., Hoekzema A.S., WatanabeE., Muenzer J.T., McDonough J.S., Tschoep J., Ferguson T.A., McDunnJ.E., Morre M., Hildeman D.A., Caldwell C.C., Hotchkiss R.S.: IL-7 promotesT cell viability, trafficking, and functionality and improvessurvival in sepsis. J. Immunol., 2010; 184: 3768-3779
  Google Scholar
• 57. Venet F., Chung C.S., Kherouf H., Geeraert A., Malcus C., PoitevinF., Bohé J., Lepape A., Ayala A., Monneret G.: Increased circulatingregulatory T cells (CD4+CD25+CD127-) contribute to lymphocyte anergyin septic shock patients. Intensive Care Med., 2009; 35: 678-686
  Google Scholar
• 58. Venet F., Chung G.S., Monneret G., Huang X., Horner B., GarberM., Ayala A.: Regulatory T cell populations in sepsis and trauma. J.Leukoc. Biol., 2008; 83: 523-535
  Google Scholar
• 59. Venet F., Foray A.P., Villars-Méchin A., Malcus C., Poitevin-LaterF., Lepape A., Monneret G.: IL-7 restores lymphocyte functionsin septic patients. J. Immunol., 2012; 189: 5073-5081
  Google Scholar
• 60. Venet F., Lepape A., Monneret G.: Clinical review: flow cytometryperspectives in the ICU – from diagnosis of infection to monitoringof injury-induced dysfunctions. Crit. Care, 2011; 15: 231
  Google Scholar
• 61. Venet F., Lukaszewicz A.C., Payen D., Hotchkiss R., Monneret G.:Monitoring the immune response in sepsis: a rational approach toadministration of immunoadjuvant therapies. Curr. Opin. Immunol.,2013; 25: 477-483
  Google Scholar
• 62. Walton A.H., Muenzer J.T., Rasche D., Boomer J.S., Sato B., BrownsteinB.H., Pachot A., Brooks T.L., Deych E., Shannon W.D., GreenJ.M., Storch G.A., Hotchkiss R.S.: Reactivation of multiple viruses inpatients with sepsis. PLoS One, 2014; 9: e98819
  Google Scholar
• 63. Yekebas E.F., Eisenberger C.F., Ohnesorge H., Saalmüller A., ElsnerH.A., Engelhardt M., Gillesen A., Meins J., The M., Strate T.,Busch C., Knoefel W.T., Bloechle C., Izbicki J.R.: Attenuation of sepsis-relatedimmunoparalysis by continuous veno-venous hemofiltrationin experimental porcine pancreatitis. Crit. Care Med., 2001;29: 1423-1430
  Google Scholar
• 64. Zhou F., Peng Z., Murugan R., Kellum J.A.: Blood purification andmortality in sepsis: a meta-analysis of randomized trials. Crit. CareMed., 2013; 41: 2209-2220
  Google Scholar

Pełna treść artykułu